Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Fentanyl1件: Fentanyl2件: D00320 (Name: Fentanyl),
D01399 (Name: Fentanyl citrate)		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬4件: 46, 70, 215, 231
2Fentanyl (High Dose)1件: Fentanyl2件: D00320 (Name: Fentanyl),
D01399 (Name: Fentanyl citrate)		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215
3Fentanyl (Low Dose)1件: Fentanyl2件: D00320 (Name: Fentanyl),
D01399 (Name: Fentanyl citrate)		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215
4Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl		4件: D00320 (Name: Fentanyl),
D00514 ,
D01205 ,
D01399 (Name: Fentanyl citrate)		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215
5Fentanyl transdermal patch1件: Fentanyl2件: D00320 (Name: Fentanyl),
D01399 (Name: Fentanyl citrate)		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 46
6Multi-modal pain management [Fentanyl]1件: Fentanyl2件: D00320 (Name: Fentanyl),
D01399 (Name: Fentanyl citrate)		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70
7Standard analgesia use [Fentanyl]1件: Fentanyl2件: D00320 (Name: Fentanyl),
D01399 (Name: Fentanyl citrate)		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70
8Transdermal fentanyl matrix, gabapentin2件: Fentanyl,
Gabapentin		3件: D00320 (Name: Fentanyl),
D00332 ,
D01399 (Name: Fentanyl citrate)		6件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
OPRM1,
SLC6A1 💬		12件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 70